Literature DB >> 3090401

Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli.

T J Harris, T Patel, F A Marston, S Little, J S Emtage, G Opdenakker, G Volckaert, W Rombauts, A Billiau, P De Somer.   

Abstract

cDNA clones of the mRNA coding for tissue-type plasminogen activator (t-PA) have been obtained and their nucleotide sequences compared to those reported previously. A gene coding for t-PA has been reconstructed and inserted into vectors for expression in prokaryotic cells. Relatively high levels of t-PA accumulated in inclusion bodies in Escherichia coli containing an optimized expression plasmid, but only a small proportion of the insoluble protein was recovered as active enzyme using a variety of solubilization procedures.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090401

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  13 in total

1.  Effector-assisted refolding of recombinant tissue-plasminogen activator produced in Escherichia coli.

Authors:  H Grunfeld; A Patel; A Shatzman; A H Nishikawa
Journal:  Appl Biochem Biotechnol       Date:  1992-05       Impact factor: 2.926

2.  Improving the resistance of a eukaryotic β-barrel protein to thermal and chemical perturbations.

Authors:  Dennis Gessmann; Frauke Mager; Hammad Naveed; Thomas Arnold; Sara Weirich; Dirk Linke; Jie Liang; Stephan Nussberger
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

3.  Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT).

Authors:  J M Rox; J Reinartz; M D Kramer
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

4.  Nucleotide sequence of the tissue-type plasminogen activator cDNA from human fetal lung cells.

Authors:  H Sasaki; Y Saito; M Hayashi; K Otsuka; M Niwa
Journal:  Nucleic Acids Res       Date:  1988-06-24       Impact factor: 16.971

5.  Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli.

Authors:  J Manosroi; C Tayapiwatana; F Götz; R G Werner; A Manosroi
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

Review 6.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

Review 7.  Disulfide bond formation in prokaryotes: history, diversity and design.

Authors:  Feras Hatahet; Dana Boyd; Jon Beckwith
Journal:  Biochim Biophys Acta       Date:  2014-02-25

8.  Expression profiles of fibrinolytic components in nasal mucosa.

Authors:  Takayuki Sejima; Seiji Madoiwa; Jun Mimuro; Teruko Sugo; Takashi Ishida; Keiichi Ichimura; Yoichi Sakata
Journal:  Histochem Cell Biol       Date:  2004-06-12       Impact factor: 4.304

9.  Human elongation factor 1 alpha: a polymorphic and conserved multigene family with multiple chromosomal localizations.

Authors:  G Opdenakker; Y Cabeza-Arvelaiz; P Fiten; R Dijkmans; J Van Damme; G Volckaert; A Billiau; A Van Elsen; B Van der Schueren; H Van den Berghe
Journal:  Hum Genet       Date:  1987-04       Impact factor: 4.132

10.  Control of formation of active soluble or inactive insoluble baker's yeast alpha-glucosidase PI in Escherichia coli by induction and growth conditions.

Authors:  E Kopetzki; G Schumacher; P Buckel
Journal:  Mol Gen Genet       Date:  1989-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.